Phase 2 Study Suggests That Extended Dosing of Aranesp(R) is as Efficacious as Weekly Dosing Read more about Phase 2 Study Suggests That Extended Dosing of Aranesp(R) is as Efficacious as Weekly Dosing
New Biomarker Data Links KRAS Gene to Vectibix(TM) Clinical Response Read more about New Biomarker Data Links KRAS Gene to Vectibix(TM) Clinical Response
Aranesp(R) DAHANCA 10 Study Results Presented at ECCO Annual Meeting Read more about Aranesp(R) DAHANCA 10 Study Results Presented at ECCO Annual Meeting
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee Read more about Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union Read more about Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union
Amgen Oncology Highlights Upcoming Data Presentations at the 2007 European Conference on Clinical Oncology Read more about Amgen Oncology Highlights Upcoming Data Presentations at the 2007 European Conference on Clinical Oncology
Aranesp(R) Study Showing No Negative Impact on Survival in SCLC Presented at World Conference on Lung Cancer Read more about Aranesp(R) Study Showing No Negative Impact on Survival in SCLC Presented at World Conference on Lung Cancer
Amgen Foundation Awards Grant to Mentor LA to Help Improve Public High School Education in Los Angeles Read more about Amgen Foundation Awards Grant to Mentor LA to Help Improve Public High School Education in Los Angeles
Court Rules That Roche Infringes One of Amgen's Erythropoietin Patents Read more about Court Rules That Roche Infringes One of Amgen's Erythropoietin Patents
Amgen Restructures Due to Lower Aranesp(R) Revenues While Continuing to Invest in Innovation and Future Growth Read more about Amgen Restructures Due to Lower Aranesp(R) Revenues While Continuing to Invest in Innovation and Future Growth
